Your browser doesn't support javascript.
loading
Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis.
Garin, Noe; Zarate-Tamames, Borja; Gras-Martin, Laura; Milà, Raimon; Crespo-Lessmann, Astrid; Curto, Elena; Hernandez, Marta; Mestres, Conxita; Plaza, Vicente.
Afiliação
  • Garin N; Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
  • Zarate-Tamames B; School of Health Science Blanquerna, Universitat Ramon Llull, 08025 Barcelona, Spain.
  • Gras-Martin L; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, 28007 Madrid, Spain.
  • Milà R; Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
  • Crespo-Lessmann A; Department of Medicine, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
  • Curto E; Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
  • Hernandez M; School of Health Science Blanquerna, Universitat Ramon Llull, 08025 Barcelona, Spain.
  • Mestres C; Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
  • Plaza V; Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain.
Pharmaceuticals (Basel) ; 16(3)2023 Mar 08.
Article em En | MEDLINE | ID: mdl-36986513
ABSTRACT
We conducted a systematic review and meta-analysis to gain insight into the characteristics and clinical impact of electronic monitoring devices of inhalers (EMDs) and their clinical interventions in adult patients with asthma or COPD. The search included PubMed, Web of Science, Cochrane, Scopus and Embase databases, as well as official EMDs websites. We found eight observational studies and ten clinical trials, assessing a wide range of clinical outcomes. Results from the meta-analysis on adherence to inhalers in a period over three months were favourable in the EMD group (fixed effects model SMD 0.36 [0.25-0.48]; random effects model SMD 0.41 [0.22-0.60]). An exploratory meta-analysis found an improvement in ACT score (fixed effect model SMD 0.25 [0.11-0.39]; random effects model SMD 0.47 [-0.14-1.08]). Other clinical outcomes showed mixed results in the descriptive analyses. The findings of this review highlight the benefits of EMDs in the optimization of adherence to inhaled therapy as well as the potential interest in other clinical outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article